FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes compounds of the formula (I): R1-OP(O)(OH)2 where R1 means the group of the formula (Ia) where R2 means phenyl substituted with one or some halogen atoms; R3 means H or CH3; R3a means H or in common with R3 can mean =CH2; R4 means 5- or 6-membered nitrogen-containing heterocyclic ring that is substituted at random with one or more groups taken among halogen atom, = O, phenyl substituted with the group taken among CN and (C6H4)-OCH2CF2CHF2 or CH=CH-(C6H4)OCH2CF2CHF2 or phenyl substituted with one or more groups taken among halogen atom and methylpyrazolyl, or its pharmaceutically acceptable salt. The above indicated triazole derivatives can be used in therapy, in part, for treatment of human and other mammals with fungal infections. Invention describes also methods of their synthesis, pharmaceutical composition, method of treatment and prophylaxis of fungal infections and intermediate compound. EFFECT: improved method of synthesis, treatment and prophylaxis, valuable antifungal properties. 7 cl, 2 dwg, 3 tbl
Title |
Year |
Author |
Number |
METHOD OF SYNTHESIS OF TRIAZOLES, ULTIMATE AND INTERMEDIATE COMPOUNDS OF METHOD |
1996 |
- Majkl Batters
- Dzhuli Ehnn Kharrison
- Alan Dzhon Pettman
|
RU2156760C2 |
QUINOXALINE DERIVATIVES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Majkl Dzhonatan Frej
- Charl'Z Ehrik Moubrej
- Alan Stoubi
|
RU2135484C1 |
METHOD OF PREPARING (S)-ENANTIOMERS |
1994 |
|
RU2114103C1 |
DERIVATIVES OF (AZETHIDINE-1-YLALKYL)-LACTAMES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT OF HUMANS WHEN PATIENTS ARE TREATED BY PRODUCING ANTAGONISTIC EFFECT ON TACHYKININ ACTING IN HUMAN NK-, NK- AND NK-RECEPTORS OR IN THEIR COMBINATION |
1995 |
- Makenzi Aleksandr Roderik
- Marchington Alan Patrik
- Middlton Donal'D Stjuart
- Midouz Sandra Dora
|
RU2150468C1 |
DERIVATIVES OF OXA- OR THIADIZOLE, METHODS OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION |
1997 |
- Aleksandr Roderik Makkenzi
- Ehntoni Vud
- Robert Dzhon Bass
|
RU2162848C2 |
3-AZETHIDINYLALKYLPIPERIDINES OR PYRROLIDINES AS TACHYKININE ANTAGONISTS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT |
1996 |
- Aleksandr Roderik Makkenzi
- Allan Patrik Marchington
- Donal'D Stjuart Middleton
- Sandra Dora Medous
|
RU2158264C2 |
BENZOPYRANES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1994 |
- Aleksandr Roderik Makkenzi
- Sandra Marina Monagan
|
RU2122000C1 |
CRYSTALLINE POLYMORPHOUS FORM OF (S,S,S)-(N-(1-[2-CARBOXY-3- -N-MESYLLYSYLAMINO)PROPYL]-1-CYCLOPENTYLCARBONYL)TYROSINE, METHODS OF ITS SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT |
1994 |
- Piter Dzhejms Dann
- Majkl Lesli Kh'Juz
|
RU2131869C1 |
(R)-(METHYLAMINOSULFONYLMETHYL)-3-(N-METHYLPYRROLIDINE-2-YL- -METHYL)-1H-INDOLE FUMARATE, METHOD OF ITS PREPARING, AGENT FOR TREATMENT OF MIRGAINE, PHARMACEUTICAL COMPOSITION FOR MIGRAINE TREATMENT |
1996 |
|
RU2161618C2 |
METHOD OF SYNTHESIS OF DIOXOAZABICYCLOHEXANES |
1996 |
- Stiven Dzhejms Rehj
- Dzhon Artur Rampas
|
RU2156238C2 |